FDA approves gene therapy worth $2.8 million.
The Bluebird Bio product Zynteglo, a gene therapy used to treat beta-thalassemia in patients, received FDA approval on Wednesday. ...
The Bluebird Bio product Zynteglo, a gene therapy used to treat beta-thalassemia in patients, received FDA approval on Wednesday. ...
© 2022 Business Forecast